158 related articles for article (PubMed ID: 34233647)
1. MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma.
Gu Y; Hu X; Liu X; Cheng C; Chen K; Wu Y; Wu Z
BMC Cancer; 2021 Jul; 21(1):784. PubMed ID: 34233647
[TBL] [Abstract][Full Text] [Related]
2. MCM6 is a Poor Prognostic Biomarker and Promotes Progression in Breast Cancer.
Lei Z; Wang P; Jia DQ; Li LL; Wu YP; Yang Y; Pan GQ
Front Biosci (Landmark Ed); 2023 Aug; 28(8):128. PubMed ID: 37664925
[TBL] [Abstract][Full Text] [Related]
3. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.
Liu Z; Li J; Chen J; Shan Q; Dai H; Xie H; Zhou L; Xu X; Zheng S
BMC Cancer; 2018 Feb; 18(1):200. PubMed ID: 29463213
[TBL] [Abstract][Full Text] [Related]
4. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
[TBL] [Abstract][Full Text] [Related]
5. Cytometry of chromatin bound Mcm6 and PCNA identifies two states in G1 that are separated functionally by the G1 restriction point.
Frisa PS; Jacobberger JW
BMC Cell Biol; 2010 Apr; 11():26. PubMed ID: 20398392
[TBL] [Abstract][Full Text] [Related]
6. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma.
Li X; Ren Z; Xiong C; Geng J; Li Y; Liu C; Ren C; Liu H
Oncol Rep; 2020 Sep; 44(3):987-1002. PubMed ID: 32583000
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of MCM6 predicts poor survival in patients with glioma.
Cai HQ; Cheng ZJ; Zhang HP; Wang PF; Zhang Y; Hao JJ; Wang MR; Wan JH
Hum Pathol; 2018 Aug; 78():182-187. PubMed ID: 29753008
[TBL] [Abstract][Full Text] [Related]
8. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer.
Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J
Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966
[TBL] [Abstract][Full Text] [Related]
9. Downregulated NORAD in neuroblastoma promotes cell proliferation via chromosomal instability and predicts poor prognosis.
Yu Y; Chen F; Jin Y; Yang Y; Wang S; Zhang J; Chen C; Zeng Q; Han W; Wang H; Guo Y; Ni X
Acta Biochim Pol; 2020 Dec; 67(4):595-603. PubMed ID: 33326736
[TBL] [Abstract][Full Text] [Related]
10. Identification of the role of MCM6 in bladder cancer prognosis, immunotherapy response, and in vitro experimental investigation using multi-omics analysis.
Wang J; Li X; Chen S; Cao J; Fan X; Wang H; Zhang X; Yang L
Life Sci; 2023 Dec; 335():122253. PubMed ID: 37951536
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.
Hotton J; Agopiantz M; Leroux A; Charra-Brunaud C; Marie B; Busby-Venner H; Morel O; Guéant JL; Vignaud JM; Battaglia-Hsu SF; Gauchotte G
Virchows Arch; 2018 Apr; 472(4):623-633. PubMed ID: 29243125
[TBL] [Abstract][Full Text] [Related]
12. High MCM6 Expression as a Potential Prognostic Marker in Clear-cell Renal Cell Carcinoma.
Jang NR; Baek J; Ko Y; Song PH; Gu MJ
In Vivo; 2021; 35(1):299-306. PubMed ID: 33402477
[TBL] [Abstract][Full Text] [Related]
13. The DNA replication regulator MCM6: An emerging cancer biomarker and target.
Zeng T; Guan Y; Li YK; Wu Q; Tang XJ; Zeng X; Ling H; Zou J
Clin Chim Acta; 2021 Jun; 517():92-98. PubMed ID: 33609557
[TBL] [Abstract][Full Text] [Related]
14. REC8 regulates neuroblastoma cell proliferation, migration, invasion, and angiogenesis via STAT3/VEGF signaling.
Wang Q; Fan W; Hao Z; Liang B; Fan M; Zhao Z; Li Z
J Egypt Natl Canc Inst; 2023 Dec; 35(1):41. PubMed ID: 38105365
[TBL] [Abstract][Full Text] [Related]
15.
Hou L; Zeng X; Li X; Zhao C; Zou J; Li Y; Liu G
Comput Math Methods Med; 2022; 2022():3116303. PubMed ID: 35720029
[TBL] [Abstract][Full Text] [Related]
16. UBE3A and MCM6 synergistically regulate the proliferation and migration of lung adenocarcinoma cells.
Luo Y; Yang Y; Yang C; Li C; Hu R; Geng W; Kang X; Lin H
FEBS Open Bio; 2023 Sep; 13(9):1756-1771. PubMed ID: 37454373
[TBL] [Abstract][Full Text] [Related]
17. Expression of minichromosome maintenance proteins in vascular smooth muscle cells is ERK/MAPK dependent.
Bruemmer D; Yin F; Liu J; Kiyono T; Fleck E; Van Herle AJ; Law RE
Exp Cell Res; 2003 Oct; 290(1):28-37. PubMed ID: 14516785
[TBL] [Abstract][Full Text] [Related]
18. High expression of minichromosome maintenance protein 6 in classic Hodgkin's lymphoma points to a cell cycle arrest in G1 phase.
Karimi S; Mohammadi F; Khodadad K; Emami H; Seyfollahi L
Arch Iran Med; 2008 Sep; 11(5):532-8. PubMed ID: 18759521
[TBL] [Abstract][Full Text] [Related]
19. Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma.
Vigouroux C; Casse JM; Battaglia-Hsu SF; Brochin L; Luc A; Paris C; Lacomme S; Gueant JL; Vignaud JM; Gauchotte G
Lung Cancer; 2015 Aug; 89(2):189-96. PubMed ID: 26013954
[TBL] [Abstract][Full Text] [Related]
20. Minichromosome Maintenance Complex is Required for Checkpoint Kinase 2 Chromatin Loading and its Phosphorylation to DNA Damage Response in SCC-4 Cells.
Li L; Feng Y; Luo R
Protein Pept Lett; 2017; 24(3):223-228. PubMed ID: 27964702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]